Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - wang
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
A Viral Exposure Signature to Define and Detect Early Onset Hepatocellular Carcinoma
Abstract: Early detection of liver cancer, such as hepatocellular carcinoma (HCC), is key to improve cancer-related mortality. More than 800,000 people are diagnosed with this cancer each year throughout the world. Liver cancer is also a leading cause of cancer deaths worldwide, accounting for more than 700,000 deaths each year. Currently, millions...
Published: 4/8/2024
|
Inventor(s):
Xin Wei
Wang
,
Jinping Liu
,
Wei Tang
Keywords(s):
Biomarker
,
HCC
,
hepatocellular carcinoma
,
Liver cancer
,
viral infection
,
Wang
Category(s):
Collaboration Sought > Licensing
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Oncology
,
Application > Diagnostics
Topoisomerase III (TOP3) Inhibitors and Antiviral Compounds based on Cyanine Dyes
Topoisomerase 3B (TOP3B) is the only topoisomerase that can act on RNA as well as DNA, and thus has been a target of interest for the development of cancer therapies and RNA viral infection therapies. In the context of cancer, TOP3B is not an essential gene, but a subset of cancer cells with pre-existing genome instability are particularly vulnerable...
Published: 12/18/2024
|
Inventor(s):
Yves Pommier
,
Shar-yin Huang
,
Wenjie
Wang
,
Weidong
Wang
,
Sourav Saha
,
Tianyi Zhang
,
Mariano Garcia-Blanco
,
Pei-Yong Shi
,
Yuk-Ching Tse-Dinh
,
Debbie Kennedy-Boone
Keywords(s):
CANCER
,
Cyanine Dye
,
NIA
,
Pommier
,
SARS-CoV-2
,
TOP
,
TOP3
,
TOP3 Inhibitor
,
TOPOISOMERASE
,
Topoisomerase III
,
Topoisomerase Inhibitor
,
viral infection
,
Wang
Category(s):
Application > Therapeutics
,
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Oncology